A painful and disfiguring disease affecting more than 100 million people worldwide could be wiped out by 2020, say experts.
Lymphatic filariasis (LF), often called elephantiasis, is caused by parasitic worms and causes grotesque swelling of the limbs, breasts and genitals.
A World Health Organisation-sponsored drive has delivered 1.9 billion doses of a simple cure since 2000.
Pharmaceutical firms have offered drugs free, keeping costs minimal.
The success of the programme was highlighted in a paper in the Public Library of Science Neglected Tropical Diseases journal.
The project, masterminded by the Global Programme to Eliminate LF, has so far prevented an estimated 6.6 million children from catching the condition, and stopped it from progressing in another 9.5 million people who already have it.
It is thought to be the most rapidly expanding drug administration programme in public health history.
Dr Mwele Malecela, who chairs the programme, said: "We are on track to accomplish our goal of elimination by 2020.
"When we do, this programme will be a leading case study for how to scale up disease elimination programmes globally".
There are 83 countries in the world where the disease is endemic, and the programme has so far administered treatments in 48 of them, to more than 570 million people.
The scale of the challenge is immense - approximately one fifth of the world's population, or 1.3 billion people, is said to be "at risk" of contracting LF.
Other benefits
The treatment uses a combination of two drugs, both donated free of charge from GlaxoSmithKline and Merck and Co.
These need to be given once a year for five years to ensure that the disease does not spread.
Another benefit of the drugs is that they also tackle intestinal worms, and approximately 100 million children and women have been treated for these.
Professor David Molyneux, from the Liverpool School of Hygiene and Tropical Medicine, and the Executive Secretary of the campaign, said that the success of the project was "staggering".
"In some countries we are talking about costs of five pence per person, per year.
"We are reaching hundreds of millions of the world's poorest people, and it's the additional benefits these drugs bring which are really important.
"I think that compared to most other public health programmes, it's going remarkably well."
Source: BBC
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Tags:
Latest Stories
-
Nigeria’s Regional Development boss, Samuel Ogbuku nominated for Africa’s top award in Marrakesh.
34 minutes -
Barcelona beat Atletico to set up Real Madrid final in Copa del Rey
2 hours -
Pharmaceutical Society of Ghana shortlists 48 for Pharma Excellence Awards
2 hours -
Top companies and individuals recognised at 8th Ghana-West Africa Healthcare Excellence Awards
3 hours -
‘All deducted E-Levy must be refunded immediately’ – GRA warns charging entities
3 hours -
‘No more E-Levy, effective immediately’ – GRA orders compliance with tax abolition
3 hours -
GAF probes alleged assault by soldiers in Kumasi; places officers under close arrest
4 hours -
Physical Planners commend Mahama for swift action on waterway demolitions
4 hours -
2025 budget prioritises health, but funding gaps remain – ARHR
4 hours -
Photos: IGP Yohuno seeks counsel with former IGPs
4 hours -
Energy and Green Transition Minister receives advisory report on private sector role in power distribution
4 hours -
Painter accused of stealing BoG cables granted GH₵1m bail
4 hours -
Mahama orders speedy desilting of Odaw drain to prevent flooding
4 hours -
Bono Regional Prison Commander honoured at a pull-out ceremony after 32 years of service
4 hours -
Kennedy Agyapong’s electoral perspective provides insight into Ghana’s political realities, not divisiveness
5 hours